Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

Exit

Acquired byNovartis
Price$620M
Date12/2009

General Information

Offices

San Carlos, USA
150 Industrial Road
c/o Novartis
San Carlos, CA, 94070
USA

Funding

Tags

Corthera

Corthera Inc., formerly BAS Medical, is a biopharmaceutical company committed to acquiring, developing and commercializing therapies for illnesses in the acute care setting. Corthera’s lead product candidate, relaxin, is currently being evaluated in a global, phase 2/3 clinical trial for acute decompensated heart failure. Corthera has worldwide rights to develop and commercialize relaxin.

Recent Milestones

Videos

Screenshots

Corthera screenshot
Above: Corthera
Uploaded: 7/14/09

Sources

  1. Novartis to acquire Corthera Inc., gaining worldwide rights to Phase III project relaxin for treatment of acute decompensated heart failure (novartis.com) [edit]
  2. Corthera Closes $23 Million Financing Round (basmedical.com) [edit]
Edit This Page
Last Edited 5/22/13

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy